Retatrutide – 20mg

It is a triple receptor agonist that targets glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors, offering a unique approach to metabolic management.

Retatrutide’s innovative mechanism involves the simultaneous activation of GLP-1, GIP, and glucagon receptors, which synergistically enhance insulin secretion, improve glucose homeostasis, and modulate appetite.

FOR RESEARCH USE ONLY. NOT FOR HUMAN CONSUMPTION.

The products and information discussed on this website are intended for laboratory and research purposes only. They are not intended for human consumption or use in any form. Any use of these products for human consumption or any other purpose is strictly prohibited and may be harmful.